Glass House Brands (GLAS) Other Operating Expenses (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Other Operating Expenses of $6.9 million for Q1 2026, down 0.76% quarter-over-quarter from $6.9 million in Q4 2025.
Glass House Brands (GLAS) Other Operating Expenses (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Other Operating Expenses for 7 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $26.2 million (up 369.43% YoY), while the FY2025 annual figure was $26.7 million, down 8.2% from the prior year.
- Other Operating Expenses fell to $6.9 million in Q1 2026 per GLAS's latest filing, from $6.9 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $31.1 million in Q3 2022 and bottomed at $5.6 million in Q2 2024.
- Historically, Other Operating Expenses has averaged $10.8 million across 5 years, with a median of $6.7 million in 2025.
- Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 967.3% — and 2024, when it decreased 21.34%.
- Glass House Brands' Other Operating Expenses stood at $24.9 million in 2022, then tumbled by 71.45% to $7.1 million in 2023, then declined by 21.34% to $5.6 million in 2024, then increased by 24.31% to $6.9 million in 2025, then retreated by 0.76% to $6.9 million in 2026.
- Business Quant data shows GLAS's Other Operating Expenses at $6.9 million in Q1 2026, $6.9 million in Q4 2025, and $6.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Glass House Brands | 831.09 Mn | 812.54 Mn | 15.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 6.94 Mn |
| Sep 30, 2025 | 6.51 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Jun 30, 2024 | 5.58 Mn |
| Jun 30, 2023 | 7.10 Mn |
| Dec 31, 2022 | 24.87 Mn |
| Sep 30, 2022 | 31.12 Mn |
| Jun 30, 2022 | 6.31 Mn |
| Mar 31, 2022 | 6.48 Mn |
| Dec 31, 2021 | -2.87 Mn |
| Sep 30, 2021 | 3.22 Mn |
| Jun 30, 2021 | 2.69 Mn |
| Mar 31, 2021 | 4.08 Mn |
| Dec 31, 2020 | 1,268.65 Bn |
| Sep 30, 2020 | 1.05 Mn |
| Mar 31, 2020 | 1.18 Mn |